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Mre11, Rad50, and Nbs1 (MRN) form an 
evolutionarily conserved protein complex that 
mediates diverse functions critical for maintain-
ing genomic stability (1–9). Loss of function 
mutations in mice lead to early embryonic 
  lethality in vertebrates (10–12), which refl  ects 
the essential role of the complex in DNA recom-
bination during normal replication (9, 13–15). 
In addition to its critical function during S 
phase, MRN infl  uences the induction of cell-
cycle checkpoints in response to DNA damage 
away from replication forks. This checkpoint 
function has been linked to MRN’s role as an 
upstream activator (1–5, 7, 16–19) and a down-
stream target of the ataxia telangiectasia mu-
tated (ATM) kinase (20–23).
MRN complexes become associated with 
double-strand breaks (DSBs) within seconds 
  after DSB formation (24). Once bound, MRN 
attracts the ATM kinase to the DSB site by several 
mechanisms, including direct interactions be-
tween ATM and a conserved C-terminal region 
in Nbs1 (7, 25, 26). In the presence of an intact 
MRN complex, ATM becomes activated by an 
as yet undefi  ned mechanism (27–29) and phos-
phorylates numerous substrates, including Nbs1 
at residues S278 and S343 (20–23). This is fol-
lowed by an escalating accumulation of MRN 
and other proteins into irradiation (IR)-induced 
foci, corresponding to large chromatin domains 
fl  anking the DSB (30). The primary function 
of this large-scale chromatin retention may be 
to amplify the DSB signal (31). If the damage 
or DSB signal is too severe, the cell undergoes 
programmed cell death, which is partially de-
pendent on the activity of ATM (32, 33).
Ectopic expression of mutated Nbs1 con-
structs into Nijmegen breakage syndrome 
(NBS) patient cell lines, which harbor hypo-
morphic mutations in Nbs1 (34, 35), have been 
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in the DNA damage response.
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used to determine the role of distinct Nbs1 domains in the ac-
tivation of ATM and its downstream eff  ectors. The N-terminal 
forkhead-associated (FHA) and BRCT domains of Nbs1, al-
though dispensable for localization of MRN to the nucleus, 
are required for the accumulation of MRN into IR-induced 
foci (36, 37). The association with chromatin is mediated by 
interactions between the FHA and BRCT domains of Nbs1 
and MDC1 and γ-H2AX (24, 38, 39). The N-terminal do-
main has been reported to be essential for cell survival in re-
sponse to IR, optimal activation of ATM, and for the intra–S 
phase checkpoint (2, 3, 26, 36, 37, 40, 41). In addition to the 
FHA domain, ATM-dependent phosphorylations of Nbs1 at 
Ser278 and S343, as well as structural maintenance of chro-
mosomes (SMC) 1 at S957 and S966, regulate the intra–S 
phase checkpoint (20–23, 42, 43). It remains unclear how the 
FHA phosphothreonine-specifi  c protein–protein interaction 
motif (44) is linked with S phase checkpoint-specifi  c phos-
phorylations, although it has been reported that mutations in 
the Nbs1 FHA domain impair ATM-dependent Nbs1 but 
not SMC1 phosphorylation (2, 26, 36, 37). One report (45), 
but not others (2, 42), has concluded that Nbs1 phosphoryla-
tion is required for SMC1 phosphorylation.
The evolutionarily conserved C-terminal 20 aa of Nbs1 
interact with ATM (25, 46, 47). Transfection of Nbs1 de-
leted in the C-terminal domain (Nbs1∆C) did not comple-
ment NBS cells, as indicated by the impairment in ATM and 
Figure 1.  Expression of human Nbs1 mutants from a BAC transgene 
in mice defi  cient for mNbs1. (A) Diagram of Nbs1WT, Nbs1657∆5, Nbs1H45A, 
Nbs1tr735, and Nbs1S278/343A proteins. Locations of the FHA, BRCT, Mre11-
binding domains, S278 and S343 phosphorylation sites, and the conserved 
C-terminal protein interaction are shown. (B) Generation of mice harboring 
premature C-terminal truncation in Nbs1 (Nbs1tr735). Conformation of 
  expression by reduced size using an Nbs1 antibody raised against aa 395–743. 
Another Nbs1 antibody that was raised against the last 20 aa of Nbs1 
(aa 735–754) does not recognize the Nbs1tr735 mutant species. (C) Genera-
tion of mice expressing the Nbs1 phosphorylation mutant, Nbs1S278/343A. 
Absence of phosphorylation was confi  rmed using phosphospecifi  c antibod-
ies and reduced mobility shift of mutant Nbs1 after IR (doses as indicated).JEM VOL. 204, May 14, 2007  1005
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downstream target phosphorylations and checkpoint defects 
in response to IR (25, 26). Moreover, Nbs1∆C did not stimu-
late DSB-induced ATM autophosphorylation in Xenopus egg 
extracts (46). These phenotypes are correlated with the failure 
to stimulate ATM recruitment to sites of DSBs (25, 46) and 
to convert ATM dimers to active monomers (48). Thus, all 
studies to date indicate that activation of ATM after DSB for-
mation requires interaction with the Nbs1 C terminus.
One potential confounding issue in these studies is that 
the cell lines used to assess the various Nbs1 mutants ex-
pressed a hypomorphic allele of NBS (49). This results in 
  expression of a C-terminal species (Nbs1p70) lacking FHA/
BRCT domains but containing ATM phosphorylation sites, 
as well as domains necessary for interaction with Mre11 and 
ATM (49) that can fulfi  ll the essential functions of the MRN 
complex. Moreover, the Nbs1p70 species varies widely between 
diff  erent NBS cell lines, being expressed at high levels in 
lymphoblastoid cells and undetectable in fi  broblasts (49). 
Therefore, it is possible that the biological impact of ex-
pressing various Nbs1 mutants in the context of this variant 
C-terminal species may be quite diff  erent from reconstitution 
of a true Nbs1-null cell line. Finally, the cell lines used in 
transfection studies were either immortalized or transformed, 
making the impact of additional mutations unpredictable.
To circumvent these diffi   culties, we established a robust 
system whereby we reconstitute Nbs1 knockout mice with 
human bacterial artifi  cial chromosome (BAC) transgenes car-
rying specifi  cally engineered mutations in diff  erent Nbs1 do-
mains. This has enabled us to analyze and evaluate the impact 
of these mutations in primary cells of diff  erent origin and 
within the context of the entire organism.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
To determine the role of various Nbs1 domains in aff  ecting 
ATM activity, we used BAC recombineering to mutate a BAC 
clone (255A7) containing the human Nbs1 gene, which was 
previously demonstrated to rescue the embryonic lethality and 
completely reconstitute Nbs1 knockout mice (7). Five BAC 
transgenes were crossed into an endogenous Nbs1-defi  cient 
background (Fig. 1 A): (a) Nbs1WT, which expresses the hu-
man WT BAC (7); (b) Nbs1657∆5, which is a 5-bp deletion that 
leads to the expression of a hypomorphic allele that is described 
in 95% of NBS patients (7, 34, 35); (c) Nbs1H45A, which is a 
point mutation in the FHA domain (7, 37); (d) Nbs1tr735, which 
is a truncated derivative lacking the C-terminal 20 aa residues; 
and (e) Nbs1S278A/S343A, which carries two mutations in which 
the serine S278 and S343 residues are modifi  ed to alanine. All 
of these constructs rescued the embryonic lethality of the Nbs1-
null mutation, as mice were born at predicted Mendelian fre-
quencies in intercrosses between transgene+Nbs1+/− mice.
We confi  rmed the presence of the mutations in the BAC 
by sequence analysis (not depicted) and verifi  ed protein 
Figure 2.  ATM and ATM substrate phosphorylation in primary B 
cells. (A) B cells were stimulated for 48 h and harvested for Western 
blot analysis 30 min after no treatment (0 Gy) or after γ IR (2 and 5 Gy) 
and immunoblotted with phosphospecifi  c anti-ATM Ser 1981p, anti-Chk1 
Ser 317p, and anti-Nbs1 Ser343p antibodies, as well as panspecific 
anti-ATM, anti-Nbs1, and anti-Chk2 antibodies. Phosphorylation of Chk2 
is indicated by the mobility shift. (B) B cells from Nbs1WT and Nbs1tr735 
mice were treated with 2 Gy of ionizing radiation, and extracts were 
prepared at the indicated time points after IR and immunoblotted 
as indicated.1006  REGULATION OF CHECKPOINTS AND APOPTOSIS BY NBS1 | Difi  lippantonio et al.
  expression and size by Western blot analysis (Fig. 1 and Fig. 
2 A). Nbs1tr735 and Nbs1S278A/S343A proteins were expressed at 
similar levels (within 1.5-fold) as the full-length Nbs1WT 
transgene (Fig. 1, B and C). Nbs1tr735 mice produced a trun-
cated protein, as indicated by the fact that antibodies against 
the Nbs1 C terminus (aa 735–754) (50) failed to detect the 
protein, whereas the protein was detected using an antibody 
that recognizes the N terminus (aa 395–743; Fig. 1 B). Phos-
hospecifi  c antibodies generated against S278 and S343 de-
tected phosphorylated forms of Nbs1 in Nbs1WT mice but 
not in Nbs1S278A/S343A mice (Fig. 1 C). Moreover, we de-
tected a substantial reduction of IR-induced mobility shift in 
Nbs1 when thymocytes from Nbs1S278A/S343A were irradiated 
(Fig. 1 C). Nevertheless, it is possible that other sites within 
Nbs1 besides S278 and S343 could be phosphorylated in 
Nbs1S278A/S343A mice in response to IR (22).
To determine whether Nbs1 mutants can still form a func-
tional complex with Mre11/Rad50, we performed immuno-
precipitation and immunofl  uorescence analyses on mouse 
embryo fi   broblasts (MEFs; Fig. S1 and Fig. S2, available 
at http://www.jem.org/cgi/content/full/jem.20070319/DC1). 
Although the interaction with Nbs1 and nuclear localiza-
tion of Mre11 were not aff  ected in Nbs1H45A and Nbs1tr735 
  mutant cells, foci formation was dependent on the intact 
FHA domain but not on the C terminus, as expected (7, 
25, 36, 37).
We have previously reported that Nbs1H45A mice share 
many overlapping phenotypes with Nbs1657∆5 mice, including 
defective thymocyte and oocyte development, genomic insta-
bility, and a reduction in phosphorylation of the ATM down-
stream target Chk2 at low IR doses (7). These phenotypes 
are similarly observed, but more severe, in ATM knockout 
mice. In contrast, Nbs1S278A/S343A and Nbs1tr735 mice were fer-
tile and did not exhibit any detectable defect in B cell or T cell 
development (not depicted). Moreover, Nbs1tr735 MEFs did 
not show more γ IR–induced chromosomal aberrations rela-
tive to Nbs1WT (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20070319/DC1). To examine the cellular 
DNA damage signaling response, we measured ATM auto-
phosphorylation and substrate phosphorylation in primary 
B cells in response to γ IR (Fig. 2 A). In Nbs1S278A/S343A mice, 
there was no detectable defect in phosphorylation of ATM, 
Chk1, or Chk2. In contrast, a small reduction in the magnitude 
of some ATM substrate phosphorylations, particularly Chk1-
S317p and Chk2p was apparent in Nbs1657∆5, Nbs1H45A, and 
Nbs1tr735 B cells treated with a low dose (2 Gy) of IR. Consistent 
with ineffi   cient substrate phosphorylation at low but not high 
doses of IR, the kinetics of Chk2 phosphorylation were per-
turbed in primary Nbs1tr735 B cells relative to WT controls after 
2 Gy (Fig. 2 B), but normal after 8 Gy, of IR (not depicted).
The fi  nding that DSB signaling was not profoundly af-
fected in Nbs1tr735 mice was particularly surprising given that 
Figure 3.  DNA damage induced ATM-Nbs1 interaction and re-
cruitment of ATM to DNA breaks. (A and B) B cells from Nbs1WT and 
Nbs1tr735 mice were treated with 2 Gy of ionizing radiation, and extracts 
were prepared 30 min after IR and immunoprecipitated with anti-ATM (A) 
or anti-Nbs1 (B) and immunoblotted as indicated. (C) Distribution of ATM 
(red) in Nbs1WT and Nbs1tr735 MEFs 5 min after treatment with UV laser 
microirradiation. γ-H2AX (green) marks sites of DSBs. Digital camera 
  images reveal the individual cells. Bar, 25 μm.JEM VOL. 204, May 14, 2007  1007
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transfection of Nbs1∆C into NBS cell lines failed to comple-
ment ATM and substrate phosphorylations (25, 26). To de-
termine whether γ IR–induced signaling was indeed ATM 
dependent, we pretreated B cells with a small molecule in-
hibitor of ATM (KU55933) (51) before IR. Treatment with 
the ATM inhibitor blocked the phosphorylation of ATM, 
SMC1, Chk1, and Chk2 in Nbs1WT, Nbs1657∆5, Nbs1H45A, 
and Nbs1tr735 mice (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20070319/DC1), indicating that 
ATM mediates substrate phosphorylations in these mice.
To determine if the Nbs1 C-terminal domain is required 
for interaction with ATM, we performed immunoprecipita-
tion analysis (Fig. 3, A and B). We were able to coimmuno-
precipitate ATM and Nbs1 in WT and Nbs1tr735 mutant cells, 
indicating that the deletion of the Nbs1 C terminus clearly 
did not abrogate the Nbs1–ATM interaction (Fig. 3, A and 
B). To determine whether ATM is still capable of being re-
cruited to DNA damage in Nbs1tr735 cells, we induced DSBs 
in primary and mutant fi  broblasts using a laser microbeam. 
The assembly of ATM coincident with γ-H2AX–marked 
sites of DSBs was tracked by fl  uorescence microscopy. We 
found rapid recruitment of ATM to DSBs independent of 
Nbs1 status (Fig. 3 C). The fact that the Nbs1 C-terminal 
domain is dispensable for interaction with ATM and ATM 
recruitment to DSBs may explain why DSB signaling is not 
ablated in Nbs1tr735 mice.
NBS cells, which express a hypomorphic allele identical 
to our BAC-encoded Nbs1657∆5 transgene, show cell-cycle 
Figure 4.  Cell-cycle checkpoints, IR sensitivity, and apoptosis 
in Nbs1 mutants. (A) Comparison of the G2/M checkpoint in Nbs1WT, 
Nbs1657∆5, Nbs1H45A, Nbs1tr735, Nbs1S278/343A, Nbs1∆/−, and Atm−/− mice. 
B cells were stimulated for 48 h and irradiated with the indicated dose, 
and the mitotic cells (positive for phosphorylated histone H3 [P-H3]) 
were measured by fl  ow cytometry 1 h after IR. The percentage of P-H3–
positive cells (unirradiated/irradiated) is plotted for each genotype. Data 
are representative of at least three independent experiments. Error bars 
indicate the standard deviation. (B) The intra–S phase checkpoint in 
Nbs1WT, Nbs1657∆5, Nbs1H45A, Nbs1tr735, Nbs1S278/343A, Nbs1∆/−, and Atm−/− mice 
as a function of IR dose. B cells were stimulated for 48 h and irradiated 
with the indicated dose, and thymidine uptake was assessed 4 h after IR. 
Data from triplicate samples are normalized to the counts in unirradiated 
controls. Data are representative of at least three independent experi-
ments. Error bars indicate the standard deviation. (C) Sensitivity of 
thymocytes to IR. Mice were exposed to whole-body IR of 4 Gy, and 
thymocytes were isolated 24 h later. The viability and percentage of CD4/
CD8 thymocytes were determined by propidium iodide staining and fl  ow 
cytometry. Representative FACS profi  les are shown. The numbers in the 
quadrants indicate the percentage of cells that express either CD4 or CD8 
(CD4−CD8−, CD4+CD8+, CD4+CD8−, CD4−CD8+). (D) Average of CD4/CD8 
DP thymocytes 24 h after IR with 4 Gy in vivo. Data are a summary from 
at least fi  ve independent experiments. Error bars indicate the mean ± 
standard deviation. ***, P < 0.001 for Nbs1WT vs. Atm−/−, Nbs1WT vs. 
Nbs1tr735, and Nbs1WT vs. Nbs1H45A, and Nbs1WT vs. Nbs1657∆5. (E) Average 
of total viable thymocytes 24 h after IR with 4 Gy in vivo. Data are a 
summary from at least fi  ve independent experiments. Horizontal lines 
represent means.1008  REGULATION OF CHECKPOINTS AND APOPTOSIS BY NBS1 | Difi  lippantonio et al.
checkpoint defects and sensitivity to IR. To determine which 
of the Nbs1 domains contribute to DNA damage-induced 
cell-cycle checkpoints, we treated primary B cells with 
γ IR (Fig. 4, A and B). Nbs1WT, Nbs1S278A/S343A, Nbs1tr735, 
Nbs1H45A, Nbs1657∆5, Nbs1∆/− (B cell–specifi  c conditional null; 
reference 14), and Atm−/− B cells were assayed over a dose 
range of 0.5–10 Gy 1 h after IR. Although cells from Nbs1∆/− 
mice showed a reduction in the mitotic index similar in mag-
nitude to Atm−/− cells, the G2/M checkpoint arrest was normal 
in Nbs1WT, Nbs1tr735, and Nbs1S278/343A mice. Intermediate 
defects were observed in cells from Nbs1657∆5 and Nbs1H45A 
mice (Fig. 4 A). Similar results were obtained when we assayed 
for thymidine incorporation after IR-induced DNA damage 
(Fig. 4 B). Again, only Nbs1657∆5, Nbs1H45A, and Nbs1∆/− 
cells showed a reduction in the rate of DNA replication. 
Collectively, these results indicate that cell-cycle checkpoints 
are regulated by the DSB-induced activation of ATM through 
the MRN complex and that the Nbs1–FHA domain par-
ticipates in eliciting a full cell-cycle checkpoint arrest. In 
contrast, neither the Nbs1 C terminus nor ATM-dependent 
phosphorylations at S278 and S343 are necessary for effi   cient 
checkpoint responses.
One hallmark feature of Atm−/− mice is the resistance 
of their immature thymocytes to IR-induced apoptosis (32). 
To examine the potential role of diff  erent Nbs1 domains in 
the apoptotic response, we subjected mice to whole-body IR 
(Fig. 4, C–E). Flow cytometric analysis of thymocytes from 
WT mice 24 h after treatment with 4 Gy confi  rmed that 
they were sensitive to IR. We observed a 93% reduction in 
the total number of thymocytes (Fig. 4 E), and an ablation 
of the CD4/CD8 double-positive (DP) thymocyte popula-
tion from 80–85% in control mice to 15–30% (average 18%) 
remaining after IR (Fig. 4, C and D). As expected, ATM−/− 
thymocytes were more resistant to apoptosis, showing a 
threefold increase in viability relative to the WT (Fig. 4 E) 
and a persistence of DP thymocytes accounting for 76% of 
the population (Fig. 4 D). Nbs1tr735 mice were about three-
fold more resistant to apoptosis than WT mice (Fig. 4 E), 
and on average 51% of the irradiated thymocytes were DP 
(Fig. 4 D). Consistent with this, the number of apoptotic 
cells was reduced in Nbs1tr735 thymi relative to the WT, as 
determined by apoptosis assays and the activation of caspase 3 
in situ (Fig. S5, available at http://www.jem.org/cgi/content/
full/jem.20070319/DC1), and there was a reduction in 
phosphorylation at residue S15 of p53 (Fig. S6). In contrast, 
Nbs1H45A and Nbs1657∆5 thymocytes were exquisitely sensitive 
to IR, exhibiting an almost complete depletion in the CD4/
CD8 DP thymocyte population and reduced viability of to-
tal thymocytes compared with WT littermates (Fig. 4, C–E). 
Thus, the N and C terminus domains of Nbs1 have opposite 
eff  ects on the induction of IR-induced thymocyte apoptosis.
By using a human BAC harboring endogenous regula-
tory elements of the Nbs1 gene, we have been able to assess 
the contribution of various domains of Nbs1 in stimulating 
divergent ATM-mediated DSB response pathways in vivo 
in the complete absence of other aberrant forms of the Nbs1 
protein. As such, we arrive at surprisingly diff  erent results 
from what has as yet been reported (Fig. 5) (25, 26). In par-
ticular, the C terminus of Nbs1 was previously shown to bind 
to ATM and was required for recruitment of ATM to sites of 
DNA damage. Thus, one would predict that deletion of the 
Nbs1 C terminus in vivo would result in an AT-like pheno-
type. On the contrary, we fi  nd that Nbs1tr735 mice harboring 
a premature truncation of Nbs1, resulting in a protein lacking 
this reported ATM binding domain, do not show any defects 
in lymphocyte or germ cell development in vivo and neither 
checkpoint defects nor genomic instability in vitro. However, 
we did observe attenuated Chk2 and Chk1 phosphorylations 
in response to low-dose IR. This indicates either that the ac-
tivity of ATM is modestly compromised or that the C termi-
nus regulates the optimal binding between ATM and specifi  c 
substrates. Nevertheless, the association between Nbs1∆C 
and ATM is suffi   cient for recruitment of ATM to sites of 
DNA damage and for nearly normal ATM activation.
One possibility for the observed discrepancy could be that 
in earlier studies (25, 26), Nbs1∆C protein was   expressed in 
Figure 5.  Map of different Nbs1 domains and their physiological 
function in vivo. Our results are consistent with the above model in 
which T cell and oocyte development and DNA damage induced G2/M and 
S phase checkpoint arrest and radiation survival is dependent on the 
N-terminal FHA domain, but not on the principal residues phosphorylated 
by ATM (serine 278 and 343) or on the evolutionarily conserved 
C-terminal region of Nbs1. The C-terminal region regulates irradiation-
induced apoptosis.JEM VOL. 204, May 14, 2007  1009
BRIEF DEFINITIVE REPORT
hypomorphic NBS cells in contrast to a Nbs1−/− background. 
It would be possible that simultaneous expression of two 
hypomorphic alleles could exacerbate the phenotypes. To 
address this issue, we have generated mice doubly transgenic 
for the tr735 and the 657∆5 or H45A allele, respectively 
(Fig. S7, available at http://www.jem.org/cgi/content/full/
jem.20070319/DC1). Despite the persistence of a defect 
in Chk2 phosphorylation at low doses of IR in cells from 
Nbs1tr735/H45A and Nbs1tr735/657∆5 double-mutant mice, the cell-
cycle checkpoint defects, ovarian failure, and thymocyte devel-
opmental defects observed in Nbs1H45A and Nbs1657∆5 mice 
were completely rescued in Nbs1tr735/H45A and Nbs1tr735/657∆5 
mice (Fig. S7 and not depicted). Thus, expressing the tr735 
mutation in the context of the Nbs1657∆5 mutation is not 
fundamentally distinct from reconstitution of the Nbs1-null 
cells/mice.
Because conditional deletion of Nbs1 nearly abolishes 
ATM activity (7), there are likely to be other regions within 
Nbs1 or within the MRN complex that can compensate for 
the lack of the extreme C terminus. Consistent with this idea, 
gel fi  ltration analysis suggests that ATM makes multiple inde-
pendent direct contacts with Mre11/Rad50 and Nbs1 (6). 
Because the MRN complex is intact (Fig. S1), remains nu-
clear, and the interaction between ATM and Nbs1 is not ab-
rogated in cells lacking the Nbs1 C terminus   (Fig. 3, A and 
B), ATM should still be capable of binding Mre11 and Rad50 
in Nbs1tr735 mice. Another possibility is that mutant Nbs1 
may be compensated for by the activity of other accessory 
proteins. For example, suppression of 53BP1 was found to 
decrease ATM activation in NBS but not WT cell lines (52). 
Consistent with this idea, recent studies by Lee et al. have 
demonstrated that although MRN(∆C) is by itself incapable 
of stimulating ATM kinase activity in vitro, addition of 
53BP1 and Brca1 allows for effi   cient ATM phosphorylation 
of substrates (Paull, T., personal communication). Thus, one 
possible explanation for the observed discrepancy between 
our results and those based on transformed NBS cells is that 
these lines have acquired secondary mutations that limit the 
ability of adaptor proteins to aff  ect ATM activity.
Besides functioning upstream of ATM, Nbs1 is itself a 
target of ATM that becomes phosphorylated at sites of DSBs 
(53). Surprisingly, mice expressing a nonphosphorylatable 
form of Nbs1 at S278 and S343 fail to demonstrate any de-
tectable AT-like phenotype in vivo, nor do they exhibit a 
defect in the intra–S phase checkpoint. In contrast, NBS cell 
lines reconstituted with S278A and S343A failed to comple-
ment the S phase checkpoint defect (20–23). Interestingly, in 
NBS lymphoblastoid cells, Nbs1p70 is still phosphorylated 
in response to IR (54). Similarly, there is no impairment in 
Nbs1 phosphorylation in AT-like disorder lymphoblasts that 
carry a mutation in Mre11 but nevertheless express full-
length Nbs1 (54). Despite normal Nbs1 phosphorylation, 
both NBS and AT-like disorder cells are impaired in the in-
duction of the S phase checkpoint (54). Collectively, these 
results indicate that Nbs1 phosphorylation at S278 and S343 
is neither suffi   cient nor necessary for inducing the S phase 
checkpoint. Although we cannot exclude that other phosphory-
lation sites in Nbs1 contribute to the intra–S phase checkpoint, 
we speculate that the major phenotypic overlap between AT 
and NBS patients is caused by a role of Nbs1 upstream rather 
than downstream of ATM.
Although both the Nbs1H45A and the Nbs1tr735 mutants 
show a defect in Chk2 phosphorylation, only the FHA do-
main is required for eliciting complete DSB induced cell-
cycle checkpoints. In contrast, the C terminus is required 
for effi   cient IR-induced apoptosis. This suggests that Nbs1 
may act as a molecular switch that determines alternative 
(cell cycle arrest vs. cell death) cellular fates in response 
to DSBs. This dual role may require multiple interactions 
between MRN and ATM and/or other mediators of the 
DSB response.
MATERIALS AND METHODS
Mice. Bacteria containing the BAC RPCI21-255A7 (Research Genetics) 
were targeted using the two-step recombination method, and mice were 
generated as previously described (55). The targeting was verifi  ed by se-
quencing of the BAC. Mice were screened as previously described (7). For 
crosses of Nbs1tr735 mice with either Nbs1H45A or Nbs1657∆5 mice, tail screen-
ing was performed using the following primers: NBS–open reading frame 
(ORF; 5′-C  A  A  C  A  T  G  C  A  A  A  A  G  A  A  G  A  G  T  C  T  C  -3′), NBS-F (5′-C  A  A  C  A-
T  G  C  A  T  G  A  G  A  A  T  A  G  T  G  A  C  -3′), and NBS-R (5′-A  A  T  C  G  T  A  A  T  T  C  T  A-
C  T  C  A  G  A  G  C  T  G  -3′). NBS-ORF and NBS-R amplify a PCR product in 
Nbs1H45A or Nbs1657∆5 transgenes, whereas NBS-F and NBS-R amplify a 
PCR product in the Nbs1tr735 transgene.
Antibodies for Western blotting and immunofl  uorescence. For Western 
blotting, the following primary antibodies were used at the indicated di-
lutions: mouse anti–mouse Atm S1987p (1:500), rabbit anti–human ATM 
S1981p (1:400; Rockland Immunochemicals), mouse anti–human unphos-
phorylated ATM S1981 (1:2,500; Rockland Immunochemicals), mouse 
anti-ATM 5C2 (1:500; Novus), rabbit anti-Chk1 317p (1:500; Bethyl Labo-
ratories), mouse anti-Chk2 (1:1,500; Upstate Biotechnology), mouse anti-
tubulin (1:10,000; Sigma-Aldrich), and anti-p53 and anti-p53 S15p as 
previously described (5). Anti–mouse Atm 1987p monoclonal antibodies 
were raised by immunization with the synthetic peptide SPTFEEGSpQGT-
TISS (Becton Dickinson). Phosphospecifi  c antibodies against S343-pNbs1 
and S278-pNbs were a gift from E. Lee (University of Texas Health Sciences 
Center, San Antonio, TX). For immunofl  uorescence, MEFs were irradiated 
with a 364-nm UV laser as previously described (56), fi  xed with 4% parafor-
maldehyde, permeabilized with 0.5% Triton X-100 for 5 min, and stained 
with rabbit anti–γ-H2AX (1:1,000; a gift from W. Bonner, National Cancer 
Institute, Bethesda, MD) and mouse anti-ATM 2C1 (1:200; Santa Cruz Bio-
technology, Inc.) antibodies. For foci formation, MEFs were fi  xed in metha-
nol 24 h after IR and stained with mouse anti–γ-H2AX (1:1,000; Upstate 
Biotechnology) and rabbit anti-Mre11 (raised against glutathione S-transferase 
[GST]–Mre11 fusion protein; Spring Valley Laboratories).
Immunoprecipitation. 30 min after 10 Gy of IR, B cells were collected, 
washed once in PBS, and then lysed in TNG buff  er low (50 mM Tris-HCl 
[pH 7.5], 200 mM NaCl, 50 mM β-glyceroposphate, 0.5% Tween 20, 0.1% 
NP-40) containing protease mix and PMSF. Cell lysis was done on ice for 
30 min, followed by centrifugation at 13,000 rpm for 10 min. Protein con-
centrations of the supernatant were determined by a BCA assay kit (Pierce 
Chemical Co.). 1 mg of protein was precleared with protein A/G beads 
(Ultralink; Pierce Chemical Co.) at 4°C for 1 h and incubated with either 
3 μg S1981 (Rockland Immunochemicals) or Nbs1 (Novus) antibody over-
night at 4°C. 20 of Ultralink protein A/G beads were added for 1 h at 4°C 
to recover antibody-bound complexes. The beads were pelleted, as per the 1010  REGULATION OF CHECKPOINTS AND APOPTOSIS BY NBS1 | Difi  lippantonio et al.
manufacturer’s instructions, and washed twice with TNG buff  er low and 
twice with PBS. The washed pellet was resuspended with 1× Lamelli buff  er 
(10% Glycerol, 3% SDS, and 0.5× Upper Tris [0.5 M Tris-HCl, 0.4% SDS] 
containing no dye or β-mercaptoethanol) and boiled for 10 min with agita-
tion. The supernatant was recovered, and half was mixed with NuPAGE 
sample buff  er (Invitrogen) and dithiothreitol and run on a NuPAG 4–12% 
gradient gel, transferred, and blotted for ATM (5C2; Novus). The remaining 
fraction was run on a 6% Tris-glycine SDS gel, transferred, and blotted with 
anti–human Nbs1 (Novus) or anti–mouse Nbs1, as previously described 
(50). To determine the MRN complex assembly, immunoprecipitations 
were performed as described above, but protein lysis was performed in RIPA 
buff  er using 10 μl anti-Mre11 serum generated by immunizing rabbits with 
a GST-Mre11 fusion protein (Spring Valley Laboratories).
B cell culture, IR-induced cell-cycle checkpoints, and chromo-
somal stability. B cells were purifi  ed by CD43 depletion of splenocytes 
and cultured for 2 d in the presence of LPS and IL-4. For intra–S phase and 
G2/M checkpoints, B cells were challenged with diff  erent doses of IR and 
measured the thymidine uptake and mitotic index, as previously described 
(7). Primary MEFs were harvested 24 h after IR, and metaphase spreads were 
prepared and analyzed by DAPI staining.
Histology and apoptosis assay. Postnatal day 5 littermates were transcardi-
ally perfused with 4% paraformaldehyde in PBS 4 h after IR with 4 Gy from 
a cesium irradiator (at a rate of 391 rad/min). Tissue was removed and cryo-
protected in 25% PBS-buff  ered sucrose. 10-μm-thick sections were cut on a 
cryostat (HM500M; Microm) and used for histology and immunohistochem-
istry. Hematoxylin and eosin staining was performed according to standard 
procedures. For active caspase 3 (1:500; BD Biosciences) immunohistochem-
istry, sections were treated with citrate buff  er for antigen retrieval after incu-
bation with cleaved caspase 3 antibody overnight after quenching endogenous 
peroxidase using 0.6% hydrogen peroxide, and immunoreactivity was visual-
ized with a substrate kit (VIP; Vector Laboratories), according to the manu-
facturer’s direction. Sections were counterstained with 0.1% methyl green, 
dehydrated, and mounted in DPX (Fluka). Apoptosis was assessed by single-
stranded DNA (ssDNA) immunoreactivity and TdT-mediated dUTP-biotin 
nick-end labeling (TUNEL). Cryosections were incubated with ssDNA anti-
body (1:300; IBL Co., Ltd.) overnight and visualized with indocarbocyanine 
(Cy3; Jackson ImmunoResearch Laboratories) mounted with Vectashield 
containing DAPI (Vector Laboratories). TUNEL was performed using Apop-
Tag (Chemicon) according to the manufacturer’s protocol. Images were cap-
tured with a digital camera (SPOT; Diagnostic Instruments) and processed 
using Photoshop CS software (Adobe). Ovaries were fi  xed in 10% formalin, 
and paraffi   n sections were stained with hematoxylin and eosin.
Online supplemental material. In Fig. S1, we examined the MRN inter-
action in cells from WT and mutant Nbs1 mice by immunoprecipitation, 
and Fig. S2 shows the Mre11 and γ-H2AX foci formation in Nbs1WT, 
Nbs1657∆5, Nbs1H45A, Nbs1tr735, and Nbs1S278/343A MEFs 24 h after 0 or 10 
Gy of IR. Fig. S3 shows chromosomal aberrations in MEFs from Nbs1WT, 
Nbs1H45A, Nbs1657∆5, and Nbs1tr735 lines before and after DNA damage in-
duction. Fig. S4 depicts ATM substrate phosphorylation in WT and Nbs1 
mutants in the presence or absence of an ATM inhibitor. Fig. S5 shows re-
gional resistance in the cortex of the Nbs1tr735 mutant thymus to IR-induced 
apoptosis, as measured by apoptosis assays. Fig. S5 shows Western blots 
of p53 stabilization and phosphorylation in thymocytes from Nbs1WT, 
Nbs1tr735, and Atm−/− mice after whole-body IR and their quantitative 
analysis. Fig. S7 shows that the Nbs1tr735 allele rescues cell-cycle checkpoint, 
oocyte, and thymocyte developmental defects but not ineffi   cient Chk2 
phosphorylation of Nbs1657∆5 mice. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20070319/DC1.
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